Cardarine (GW501516) – 10mg (Oral Research Tablets)
PPARδ Agonist / Metabolic Modulator
For Research Use Only

Product Description:
Cardarine, also known as GW501516, is a synthetic peroxisome proliferator‑activated receptor delta (PPARδ) agonist. It has been widely studied in preclinical models for its effects on lipid metabolism, endurance enhancement, and fatty acid oxidation.

As a selective PPARδ activator, Cardarine promotes transcription of genes involved in energy expenditure and fat metabolism, making it a compound of interest in exercise mimetic and metabolic health research.

Research Applications:
Laboratory studies with Cardarine have explored its potential to:
Enhance fatty acid oxidation and lipid utilisation in muscle tissue.
Increase endurance capacity and exercise performance in animal models.
Support improvements in glucose tolerance and insulin sensitivity.
Investigate mechanisms of energy balance and metabolic syndrome

Dosage Form:
Supplied as 10mg oral research tablets, formulated for convenient and precise laboratory dosing.

Storage & Handling:
Store in a cool, dry environment (20–25 °C), protected from light and moisture.
For laboratory research only; not for clinical or in vivo therapeutic use.

Chemical Information:
Component: Cardarine
Synonyms: Cardarine, GW501516, GSK‑516
CAS Number: 317318‑70‑0
Molecular Formula: C₂₁H₁₈F₃NO₃S₂
Molecular Weight: ≈453.5 g/mol
Purity: ≥99% (Research Grade)

Important Notice:
This product is intended strictly for laboratory research purposes by qualified professionals.
It is not for human or veterinary consumption, nor for therapeutic, diagnostic, or clinical applications.